| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.499 | 31.576 | 1.751 | 2.554 | 6.166 | 3.619 | 6.487 | 5.886 | 19.042 | 26.532 |
| Total Income - EUR | 4.499 | 31.576 | 1.751 | 2.554 | 6.166 | 3.619 | 6.487 | 5.886 | 19.042 | 26.532 |
| Total Expenses - EUR | 430 | 497 | 465 | 208 | 236 | 232 | 218 | 269 | 18.653 | 26.890 |
| Gross Profit/Loss - EUR | 4.069 | 31.079 | 1.287 | 2.346 | 5.930 | 3.387 | 6.269 | 5.617 | 389 | -357 |
| Net Profit/Loss - EUR | 3.934 | 30.132 | 1.234 | 2.269 | 5.745 | 3.286 | 6.098 | 5.444 | 326 | -357 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Centrodiab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.979 | 3.956 |
| Current Assets | 4.647 | 31.728 | 29.807 | 31.313 | 10.764 | 8.291 | 14.211 | 5.734 | 7.642 | 7.131 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.499 | 1.336 | 27.252 | 430 | 0 | 0 | 970 | 2.140 | 5.874 | 4.972 |
| Cash | 148 | 30.392 | 2.554 | 30.884 | 10.764 | 8.291 | 13.241 | 3.593 | 1.769 | 2.159 |
| Shareholders Funds | 3.892 | 30.234 | 2.695 | 4.915 | 10.564 | 8.167 | 14.084 | 5.493 | 4.942 | 4.558 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 755 | 1.493 | 27.112 | 26.399 | 200 | 123 | 127 | 241 | 6.678 | 6.529 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Centrodiab Srl